Managing Lipid Abnormalities in Type 2 Diabetes
Lipid abnormalities are present in over 60% of people with diabetes. The decision to initiate lipid lowering treatment should be based on absolute cardiovascular risk. Calculation of cardiovascular risk is appropriate in most people with diabetes. Statins are firstline therapy for prevention of cardiovascular disease in people with diabetes. Elevated triglyceride levels are common in people with diabetes and treatment may be beneficial in some patients.
Modern Medicine – May/June 2018
